Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/12/2019
SIETES contiene 92850 citas

 
 
 1 a 20 de 287 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. Prostate cancer medicine Xofigo must not be used with Zytiga and prednisone/prednisolone. European Medical Agency 2018:1. [Ref.ID 102552]
2. Cita con resumen
Hammel P, Huguet F, van Laethem J-L, Goldstein D, Glimelius B, Artru P, Borbath I, Bouché O, Shannon J, André T, Mineur L, Chibaudel B, Bonnetain F, Louvet C. Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial. JAMA 2016;315:1844-53. [Ref.ID 100259]
3. Cita con resumen
Anónimo. Vemurafenib (Zelboraf): risk of potentiation of radiation toxicity. Drug Safety Update 2015;9:2. [Ref.ID 99642]
4. Cita con resumen
Pless M, Stupp R, Ris H-B, Stahel RA, Wder W, Thierstein S, Gerard M-A, Xyrafas A, Früh M, Cathomas R, Zippelius A, Roth A, Bijelovic M, Ochsenbein A, Meier UR, Mamot C, Rauch D, Gautschi O, Betticher DC, Mirimanoff R-O, Peters S, SAKK Lung Cancer Project Group. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial. Lancet 2015;386:1049-56. [Ref.ID 99534]
5. Cita con resumen
Anónimo. Traitements des cancers de l'enfance: effets indésirables à long terme. Prescrire 2015;35:348-52. [Ref.ID 99136]
6. Cita con resumen
Slotman BJ, van Tinteren H, Praag JO, Knegjens J, El Sharouni SY, Hatton M, Keijser A, Faivre-Finn C, Senan S. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. Lancet 2015;385:36-42. [Ref.ID 98724]
9. Cita con resumen
Mohr JP, Parides MK, Stapf Ch, Moquete E, Moy CS, Overbey JR, Al-Shahi Salman R, Vicaut E, Young WL, Houdart E, Cordonnier Ch, Stefani MA, Hartmann A, von Kummer R, Biondi A, Berkefeld J, Klijn CJM, Harkness K, Libman R, Barreau X, Moskowitz AJ, for the international ARUBA investigator. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 2014;383:614-21. [Ref.ID 97137]
10.Tiene citas relacionadas Cita con resumen
Fine HA. Bevacizumab in glioblastoma — still much to learn. N Engl J Med 2014;370:764-5. [Ref.ID 97134]
11. Cita con resumen
Tewari KS, Sill MW, Long HJ, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael HE, Monk BJ. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med 2014;370:734-43. [Ref.ID 97133]
12.Tiene citas relacionadas Cita con resumen
Chinot OL, Wick W, Mason W, Henriksson R, Saran F, Nishikawa R, Carpentier AF, Hoang-Xuan K, Kavan P, Cernea D, Brandes A, Hilton M, Abrey L, Cloughesy T. Bevacizumab plus radiotherapy–temozolomide for newly diagnosed glioblastoma. N Engl J Med 2014;370:709-22. [Ref.ID 97132]
13.Tiene citas relacionadas Cita con resumen
Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S, Won M, Jeraj R, Brown PD, Jaeckle KA, Schiff D, Stieber VW, Brachman DG, Werner-Wasik M, Tremont-Lukats IW, Sulman EP, Aldape KD, Curran WJ, Mehta MP. A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 2014;370:699-708. [Ref.ID 97131]
15.
Bascones-Martínez A, Muñoz-Corcuera M, Gómez-Font R. Efectos secundarios bucales de la radioterapia y quimioterapia en el cáncer en la región cervicofacial. Med Clin (Barc) 2013;141:77-81. [Ref.ID 95765]
16.Tiene citas relacionadas
Darby SC, Ewertz M, Hall P. Ischemic heart disease after breast cancer radiotherapy. Author/editor response. N Engl J Med 2013;368:2527. [Ref.ID 95747]
17.Tiene citas relacionadas
Vaidya JS, Bulsara M, Wenz F. Ischemic heart disease after breast cancer radiotherapy. N Engl J Med 2013;368:2525-6. [Ref.ID 95746]
18.Tiene citas relacionadas
Liu F-F, Fyles T, Liu P. Ischemic heart disease after breast cancer radiotherapy. N Engl J Med 2013;368:2524-5. [Ref.ID 95745]
19.Tiene citas relacionadas
Formenti SC, Lymberis SC, De Wyngaert JK. Ischemic heart disease after breast cancer radiotherapy. N Engl J Med 2013;368:2524. [Ref.ID 95744]
20.Tiene citas relacionadas
Toutouzas K, Benetos G, Stefanadis C. Ischemic heart disease after breast cancer radiotherapy. N Engl J Med 2013;368:2523-4. [Ref.ID 95743]
Seleccionar todas
 
 1 a 20 de 287 siguiente >>